🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Giving preoperative loading dose of 60mg of trimetazidine can safely and ef...
Status
Unknown
Location
Chinese People's Liberation Army General Hospital
Start Date
2016-07
Trial ID
NCT02826616
Treatments Being Tested
Acute myocardial injury has been a finding of variable frequency among pati...
Status
Unknown
Location
Heart Institute (InCor-HCFMUSP)
Start Date
2020-12-10
Trial ID
NCT04760821
Treatments Being Tested
The study will assess the pharmacokinetics (PK), tolerability, and safety o...
Status
Suspended
Location
Medical University of Graz
Start Date
2018-11-28
Trial ID
NCT03737448
Treatments Being Tested
Trimetazidine is a agent promoting glucose utilization by limiting fatty-ac...
Status
Completed
Location
Chinese PLA general hospital
Start Date
2020-10-01
Trial ID
NCT07325955
Contrast-associated acute kidney injury (CA-AKI) is a common complication o...
Status
Unknown
Location
Faculty of Pharmacy, Beni-Suef University
Start Date
2022-09-19
Trial ID
NCT05540184
Treatments Being Tested
The investigators set out to evaluate the effects of the traditional Chines...
Status
Unknown
Location
Dept. of Cardiology, Affiliated Zhongshan hospital of Dalian University
Start Date
2017-11-01
Trial ID
NCT03333499
Treatments Being Tested
Trimetazidine is a metabolic agent without any negative inotropic or vasodi...
Status
Completed
Location
Severance Hospital
Start Date
2010-12
Trial ID
NCT01857921
Based on accumulating evidence showing that impaired cardiac energetic meta...
Status
Unknown
Location
Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases
Start Date
2019-03-25
Trial ID
NCT03887013
Treatments Being Tested
With the improvement of people's living standard, the prevalence of Diabete...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-01
Trial ID
NCT05147194
Treatments Being Tested
This study compared the effect of Yangxinshi on exercise tolerance of patie...
Status
Completed
Location
The First Affiliated Hospital of University of Science and Technology of China
Start Date
2019-08-01
Trial ID
NCT03809273
Treatments Being Tested